BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 30562764)

  • 1. [Diagnosis and treatment of antiphospholipid antibody-related recurrent spontaneous abortion and analysis of therapeutic drugs and pregnancy outcome in 75 patients with antiphospholipid syndrome].
    Li XY; Zhao JX; Liu XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):956-961. PubMed ID: 30562764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL].
    Mekinian A; Vicaut E; Cohen J; Bornes M; Kayem G; Fain O
    Gynecol Obstet Fertil Senol; 2018; 46(7-8):598-604. PubMed ID: 30041771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid antibody syndrome.
    Kutteh WH; Hinote CD
    Obstet Gynecol Clin North Am; 2014 Mar; 41(1):113-32. PubMed ID: 24491987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome.
    Dendrinos S; Sakkas E; Makrakis E
    Int J Gynaecol Obstet; 2009 Mar; 104(3):223-5. PubMed ID: 19116178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases.
    Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; Sáez-Comet L; Lefkou E; Mekinian A; Belizna C; Ruffatti A; Tincani A; Marozio L; Espinosa G; Cervera R; Ríos-Garcés R; De Carolis S; Latino O; LLurba E; Chighizola CB; Gerosa M; Pengo V; Lundelin K; Rovere-Querini P; Canti V; Mayer-Pickel K; Reshetnyak T; Hoxha A; Tabacco S; Stojanovich L; Gogou V; Varoudis A; Arnau A; Ruiz-Hidalgo D; Trapé J; Sos L; Stoppani C; Martí-Cañamares A; Farran-Codina I;
    Autoimmun Rev; 2019 Apr; 18(4):406-414. PubMed ID: 30772493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment outcome in women suffering from recurrent miscarriages and antiphospholipid syndrome].
    Malinowski A; Dyński MA; Maciołek-Blewniewska G; Głowacka E; Pawłowski T; Babula G
    Ginekol Pol; 2003 Oct; 74(10):1213-22. PubMed ID: 14669420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT.
    van Hoorn ME; Hague WM; van Pampus MG; Bezemer D; de Vries JI;
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():168-73. PubMed ID: 26771908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment?
    de Jesús GR; Rodrigues G; de Jesús NR; Levy RA
    Curr Rheumatol Rep; 2014 Feb; 16(2):403. PubMed ID: 24390757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pregnancy outcome in 54 patients with antiphospholipid syndrome: a retrospective clinical study].
    Zheng XJ; Deng XL; Liu XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Apr; 46(2):323-8. PubMed ID: 24743831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid syndrome in obstetrics.
    Kemp M; Thomas W
    Lupus; 2018 Oct; 27(1_suppl):28-31. PubMed ID: 30452326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials.
    Lu C; Liu Y; Jiang HL
    J Matern Fetal Neonatal Med; 2019 Apr; 32(8):1299-1311. PubMed ID: 29179589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstetric antiphospholipid syndrome: an update on pathophysiology and management.
    Ernest JM; Marshburn PB; Kutteh WH
    Semin Reprod Med; 2011 Nov; 29(6):522-39. PubMed ID: 22161465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic therapy for pregnancy loss.
    de Jong PG; Goddijn M; Middeldorp S
    Hum Reprod Update; 2013; 19(6):656-73. PubMed ID: 23766357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.
    Backos M; Rai R; Baxter N; Chilcott IT; Cohen H; Regan L
    Br J Obstet Gynaecol; 1999 Feb; 106(2):102-7. PubMed ID: 10426674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.
    Triolo G; Ferrante A; Ciccia F; Accardo-Palumbo A; Perino A; Castelli A; Giarratano A; Licata G
    Arthritis Rheum; 2003 Mar; 48(3):728-31. PubMed ID: 12632426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group.
    Branch DW; Peaceman AM; Druzin M; Silver RK; El-Sayed Y; Silver RM; Esplin MS; Spinnato J; Harger J
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):122-7. PubMed ID: 10649166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases.
    Khizroeva J; Bitsadze V; Tincani A; Makatsariya A; Arslanbekova M; Babaeva N; Tsibizova V; Shkoda A; Makatsariya N; Tretyakova M; Solopova A; Gadaeva Z; Vorobev A; Khamani I; Aslanova Z; Nakaidze I; Mischenko A; Grigoreva K; Kunesko N; Egorova E; Mashkova T
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6157-6164. PubMed ID: 34044735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies.
    Lazzaroni MG; Fredi M; Andreoli L; Chighizola CB; Del Ross T; Gerosa M; Kuzenko A; Raimondo MG; Lojacono A; Ramazzotto F; Zatti S; Trespidi L; Meroni PL; Pengo V; Ruffatti A; Tincani A
    Front Immunol; 2019; 10():1948. PubMed ID: 31475009
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone.
    Kutteh WH
    Am J Obstet Gynecol; 1996 May; 174(5):1584-9. PubMed ID: 9065133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.